ReviewBiomedical engineering online2026
Application of multimodal nanotechnology and standardized nursing management in ventricular arrhythmia.
Review in Biomedical engineering online, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Ventricular arrhythmias, particularly ventricular fibrillation, remain a leading cause of sudden cardiac death and pose persistent clinical challenges due to limitations in targeted therapy and the complexity of arrhythmogenic substrates. multimodal nanotechnology has emerged as a promising platform enabling integrated diagnostic and therapeutic functions; however, direct evidence for its application in cardiology remains limited compared to oncology, and significant translational barriers persist. Concurrently, comprehensive nursing and standardized management are critical for optimizing patient outcomes through continuous monitoring, timely intervention, and holistic care. This review critically synthesizes current evidence on multimodal nanotechnology applications in ventricular arrhythmia management, distinguishing between established cardiovascular findings and conceptual extrapolations from other fields. It analyzes technological advantages alongside cardiac-specific limitations-including myocardial targeting challenges, pro-arrhythmic risks, and regulatory complexity. Furthermore, it examines how nanotechnology-based therapies will impact nursing workflows, monitoring protocols, and competency requirements, proposing a framework for integrating these innovations with standardized nursing management. By bridging cutting-edge technological advances with clinical nursing strategies, this article provides a theoretical foundation and practical guidance for fostering multidisciplinary collaboration and advancing comprehensive, patient-centered treatment paradigms for ventricular arrhythmias.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.